How prostate-specific membrane antigen level may be correlated with stemness in prostate cancer stem cell-like cell populations?

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 1, 2014, Pages 133-141

  Maria, Toloudi ^a   Panagiotis, Apostolou ^a   Marina, Chatziioannou ^a   Eleni, Kourtidou ^a   Ioanna, Vlachou ^a   Georgia, Mimikakou ^a   Ioannis, Papasotiriou ^a  

^a Research Genetic Cancer Centre Ltd   (Greece)

Author keywords

Cancer stem cell like cells; prostate cancer; prostate specific membrane antigen; stemness

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; HOMEODOMAIN PROTEIN; MEMBRANE ANTIGEN; NANOG PROTEIN, HUMAN;

ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CANCER STEM CELL; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER CELL LINE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; MULTICELLULAR SPHEROID; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL CULTURE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTIGENS, SURFACE; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLUTAMATE CARBOXYPEPTIDASE II; HETEROGRAFTS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84899681880     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.131461     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: Priorities for prevention. Carcinogenesis 2010;31:100-10.
3. Alison MR, Lim SM, Nicholson LJ. Cancer stem cells: Problems for therapy? J Pathol 2011;223:147-61.
4. Toloudi M, Apostolou P, Chatziioannou M, Papasotiriou I. Correlation between cancer stem cells and circulating tumor cells and their value. Case Rep Oncol 2011;4:44-54.
5. Kong D, Li Y, Wang Z, Sarkar FH. Cancer stem cells and epithelial-to-mesenchymal transition (EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel) 2011;3:716-29.
6. Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C. Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: Distinct, overlapping or same populations. Oncogene 2011;30:4609-21.
7. Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One 2010;5:e12445.
8. Schülke N, Varlamova OA, Donovan GP, Ma D, Gardner JP, Morrissey DM, et al. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc Natl Acad Sci U S A 2003;100:12590-5.
9. Tibbe AG, Miller MC, Terstappen LW. Statistical considerations for enumeration of circulating tumor cells. Cytometry A 2007;71:154-62.
10. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the cell search system. Clin Cancer Res 2007;13:920-8.
11. Gleghorn JP, Pratt ED, Denning D, Liu H, Bander NH, Tagawa ST, et al. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody. Lab Chip 2010;10:27-9.
12. Zhang L, Jiao M, Li L, Wu D, Wu K, Li X, et al. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties. J Cancer Res Clin Oncol 2012;138:675-86.
13. Fan X, Liu S, Su F, Pan Q, Lin T. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system. Urol Oncol 2012;30:314-8.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 2001;25:402-8.
15. Diamandis EP. Prostate-specific antigen: A cancer fighter and a valuable messenger? Clin Chem 2000;46:896-900.
16. Xu T, Chen X, Wang XF, Hou SK, Zhu JC, Zhang XD, et al. Study of PSA, PSMA and hK2 mRNA in peripheral blood of prostate cancer patients and its clinical implications. Beijing Da Xue Xue Bao 2004;36:164-8.
17. Murphy GP, Maguire RT, Rogers B, Partin AW, Nelp WB, Troychak MJ, et al. Comparison of serum PSMA, PSA levels with results of Cytogen-356 Prosta Scint scanning in prostatic cancer patients. Prostate 1997;33:281-5.
18. Panteleakou Z, Lembessis P, Sourla A, Pissimissis N, Polyzos A, Deliveliotis C, et al. Detection of circulating tumor cells in prostate cancer patients: Methodological pitfalls and clinical relevance. Mol Med 2009;15:101-14.
19. Kurek R, Nunez G, Tselis N, Konrad L, Martin T, Roeddiger S, et al. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients. Clin Cancer Res 2004;10:5808-14.
20. Conway RE, Petrovic N, Li Z, Heston W, Wu D, Shapiro LH. Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol 2006;26:5310-24.
21. rd, et al. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer. Prostate 1997;33:141-6.
22. Ben Jemaa A, Bouraoui Y, Sallami S, Banasr A, Ben Rais N, Ouertani L, et al. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies. J Exp Clin Cancer Res 2010;29:171.
23. Minner S, Wittmer C, Graefen M, Salomon G, Steuber T, Haese A, et al. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer. Prostate 2011;71:281-8.
24. Li H, Tang DG. Prostate cancer stem cells and their potential roles in metastasis. J Surg Oncol 2011;103:558-62.
25. Taylor RA, Toivanen R, Risbridger GP. Stem cells in prostate cancer: Treating the root of the problem. Endocr Relat Cancer 2010;17:R273-85.
26. Crea F, Mathews LA, Farrar WL, Hurt EM. Targeting prostate cancer stem cells. Anticancer Agents Med Chem 2009;9:1105-13.